Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUBLIME study of sublingual sufentanil versus intravenous morphine after laparoscopic donor nephrectomy
NL-OMON46204Phase 4Withdrawn
- Sponsor
- Radboud University Medical Center
- Start
- May 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sufentanil and morphine in acute postoperative pain (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Independent mobilization on postoperative day 1. Planned start May 2019; status: withdrawn.
02
Drugs
sufentanilmorphine
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NL-OMON46204.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON46204.